ES2107118T3 - Procedimiento para la preparacion de diesteres cuaternarios. - Google Patents

Procedimiento para la preparacion de diesteres cuaternarios.

Info

Publication number
ES2107118T3
ES2107118T3 ES94202451T ES94202451T ES2107118T3 ES 2107118 T3 ES2107118 T3 ES 2107118T3 ES 94202451 T ES94202451 T ES 94202451T ES 94202451 T ES94202451 T ES 94202451T ES 2107118 T3 ES2107118 T3 ES 2107118T3
Authority
ES
Spain
Prior art keywords
carbon atoms
atom
group
formula
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94202451T
Other languages
English (en)
Inventor
Burkhard Weuste
Hans Joachim Weissen
Andrea Gertrud Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2107118T3 publication Critical patent/ES2107118T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups

Abstract

SE PRESENTA UN PROCESO PARA LA PREPARACION DE DIESTERES CUATERNARIOS DE LA FORMULA: (I) EN LA QUE X- REPRESENTA UN ATOMO DE HALOGENO, NOTABLEMENTE UN ATOMO DE CLORO O UN ATOMO DE BROMO; R1 Y R2 PUEDEN SER IGUALES O DIFERENTES Y TIENEN EL SIGNIFICADO DE UN GRUPO QUE TIENEN ENTRE 1 Y 3 ATOMOS DE CARBONO, UN GRUPO DE HIDROXIETILO, O PUEDEN ESTAR UNIDAS PARA FORMAR UN GRUPO DE ALQUILENO QUE TENGA ENTRE 4 Y 6 ATOMOS DE CARBONO QUE PUEDE ESTAR INTERRUMPIDO POR UN ATOMO DE N O UN ATOMO DE O, Y R3 Y R4 PUEDEN SER IGUALES O DIFERENTES Y TIENEN EL SIGNIFICADO DE UN GRUPO DE ALQUILO O UN GRUPO DE ALQUENILO QUE TIENE ENTRE 8 Y 22 ATOMOS DE CARBONO, O PUEDEN ESTAR UNIDAS ENTRE SI PARA FORMAR UN GRUPO DE ALK(EN)ILENO QUE TENGA ENTRE 8 Y 22 ATOMOS DE CARBONO, QUE SE CARACTERIZA EN QUE: A) UN AMINO SECUNDARIO DE LA FORMULA R{SUB, 1}-NH-R{SUB, 2} SE AÑADE GRADUALMENTE Y CONVIERTE CON UNO O MAS COMPUESTOS LIQUIDOS DE LA FORMULA II O III EN UNA PROPORCION MOLAR EN LA BANDA DE ENTRE 1,0:1,0 Y 1,0:1,2 DESPUES DE LO CUAL B) EL HIDROHALURO DE AMINO SOLIDO FORMADO SE SEPARA SIGUIENTE POR C) UN POSTRATAMIENTO, OPCIONALMENTE EN UN SOLVENTE, A ELEVADA TEMPERATURA HASTA QUE LA CONVERSION ESTE VIRTUALMENTE COMPLETA, DESPUES DE LO CUAL, SI SE DESEA, UN TRATAMIENTO ADICIONAL, TAL COMO LA RECRISTALIZACION A PARTIR DE UN SOLVENTE ORGANICO, SE LLEVA A CABO PARA CONSEGUIR UNA FORMA DE PRODUCTO ESPECIAL.
ES94202451T 1994-08-29 1994-08-29 Procedimiento para la preparacion de diesteres cuaternarios. Expired - Lifetime ES2107118T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94202451A EP0699655B1 (en) 1994-08-29 1994-08-29 Process for the preparation of quaternary diesters

Publications (1)

Publication Number Publication Date
ES2107118T3 true ES2107118T3 (es) 1997-11-16

Family

ID=8217141

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94202451T Expired - Lifetime ES2107118T3 (es) 1994-08-29 1994-08-29 Procedimiento para la preparacion de diesteres cuaternarios.

Country Status (7)

Country Link
US (1) US5596125A (es)
EP (1) EP0699655B1 (es)
JP (1) JPH0867658A (es)
AT (1) ATE158568T1 (es)
CA (1) CA2157096A1 (es)
DE (1) DE69405864T2 (es)
ES (1) ES2107118T3 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2309953C2 (ru) 1999-11-03 2007-11-10 Эймр Текнолоджи, Инк. Арил- и гетероарилзамещенные тетрагидроизохинолины, фармацевтическая композиция и способ лечения на их основе
US7163949B1 (en) 1999-11-03 2007-01-16 Amr Technology, Inc. 4-phenyl substituted tetrahydroisoquinolines and use thereof
KR100821410B1 (ko) 2000-07-11 2008-04-10 에이엠알 테크놀로지, 인크. 4-페닐 치환된 테트라하이드로이소퀴놀린 및 이의치료학적 용도
ZA200701232B (en) 2004-07-15 2008-08-27 Amr Technology Inc Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
ES2382814T3 (es) 2005-05-17 2012-06-13 Merck Sharp & Dohme Ltd. Ácido cis-4-[(4-clorofenil)sulfonil]-4-(2,5-difluorofenil)ciclohexanopropanoico para el tratamiento del cáncer
EP1904069B1 (en) 2005-07-15 2018-06-13 Albany Molecular Research, Inc. Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
GB0603041D0 (en) 2006-02-15 2006-03-29 Angeletti P Ist Richerche Bio Therapeutic compounds
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
BRPI0806245B1 (pt) 2007-01-10 2022-01-25 Msd Italia S.R.L. Compostos de fórmula i e seus usos
EP2170076B1 (en) 2007-06-27 2016-05-18 Merck Sharp & Dohme Corp. 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
AR071997A1 (es) 2008-06-04 2010-07-28 Bristol Myers Squibb Co Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
US8691825B2 (en) 2009-04-01 2014-04-08 Merck Sharp & Dohme Corp. Inhibitors of AKT activity
CN102638982B (zh) 2009-05-12 2015-07-08 百时美施贵宝公司 (S)-7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉的晶型及其用途
KR20120034644A (ko) 2009-05-12 2012-04-12 알바니 몰레큘라 리써치, 인크. 아릴, 헤테로아릴, 및 헤테로사이클 치환된 테트라하이드로이소퀴놀린 및 이의 용도
CA2760837C (en) 2009-05-12 2018-04-03 Albany Molecular Research, Inc. 7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
WO2011046771A1 (en) 2009-10-14 2011-04-21 Schering Corporation SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF
CA2805265A1 (en) 2010-08-02 2012-02-09 Merck Sharp & Dohme Corp. Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)
WO2012024170A2 (en) 2010-08-17 2012-02-23 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
US8883801B2 (en) 2010-08-23 2014-11-11 Merck Sharp & Dohme Corp. Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
US8946216B2 (en) 2010-09-01 2015-02-03 Merck Sharp & Dohme Corp. Indazole derivatives useful as ERK inhibitors
EP2615916B1 (en) 2010-09-16 2017-01-04 Merck Sharp & Dohme Corp. Fused pyrazole derivatives as novel erk inhibitors
WO2012058210A1 (en) 2010-10-29 2012-05-03 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA)
WO2012087772A1 (en) 2010-12-21 2012-06-28 Schering Corporation Indazole derivatives useful as erk inhibitors
JP2014514321A (ja) 2011-04-21 2014-06-19 メルク・シャープ・アンド・ドーム・コーポレーション インスリン様増殖因子１受容体阻害剤
US9023865B2 (en) 2011-10-27 2015-05-05 Merck Sharp & Dohme Corp. Compounds that are ERK inhibitors
US20150299696A1 (en) 2012-05-02 2015-10-22 Sirna Therapeutics, Inc. SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
WO2014052563A2 (en) 2012-09-28 2014-04-03 Merck Sharp & Dohme Corp. Novel compounds that are erk inhibitors
MX363243B (es) 2012-11-28 2019-03-14 Merck Sharp & Dohme Composiciones para tratar cáncer y usos de dichas composiciones.
RU2690663C2 (ru) 2012-12-20 2019-06-05 Мерк Шарп И Доум Корп. Замещенные имидазопиридины в качестве ингибиторов hdm2
US9540377B2 (en) 2013-01-30 2017-01-10 Merck Sharp & Dohme Corp. 2,6,7,8 substituted purines as HDM2 inhibitors
US20160194368A1 (en) 2013-09-03 2016-07-07 Moderna Therapeutics, Inc. Circular polynucleotides
US10947234B2 (en) 2017-11-08 2021-03-16 Merck Sharp & Dohme Corp. PRMT5 inhibitors
EP3833668A4 (en) 2018-08-07 2022-05-11 Merck Sharp & Dohme Corp. PRMT5 INHIBITORS
WO2020033284A1 (en) 2018-08-07 2020-02-13 Merck Sharp & Dohme Corp. Prmt5 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2926772A1 (de) * 1979-07-03 1981-01-15 Hoechst Ag Quaternaere alkylamino-di-alkylcarbonsaeure-di-ester, verfahren zu deren herstellung und deren verwendung
ATE150481T1 (de) * 1992-06-10 1997-04-15 Procter & Gamble Stabile, biologisch abbaubare gewebeweichmacherzusammensetzungen

Also Published As

Publication number Publication date
ATE158568T1 (de) 1997-10-15
DE69405864T2 (de) 1998-03-26
JPH0867658A (ja) 1996-03-12
US5596125A (en) 1997-01-21
DE69405864D1 (de) 1997-10-30
CA2157096A1 (en) 1996-03-01
EP0699655B1 (en) 1997-09-24
EP0699655A1 (en) 1996-03-06

Similar Documents

Publication Publication Date Title
ES2107118T3 (es) Procedimiento para la preparacion de diesteres cuaternarios.
BR8704582A (pt) Processo para preparar derivados de piridinacarboxamida
NO308599B1 (no) Piperidinderivater og fremgangsmate for fremstilling derav
DK0979821T3 (da) Tricykliske forbindelser
DK377780A (da) Fremgangsmaade til fremstilling af phenolderivater
BR9508037A (pt) Derivados de piridona-ácido carboxilico agente anti-tumor composição farmacológica e processo para preparar derivados de piridona-ácido carboxilico
ES2039221T3 (es) Procedimiento para producir derivados de piridazinona.
DE69305045T2 (de) N-Alkoxymethylbenzamid-Derivate und Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Benzamid-Derivaten
NO911896L (no) Umettede polyesterharpikser og fremgangsmaate for fremstilling av harpiksene.
PT99043A (pt) Processo para a preparacao de composicoes biocidas contendo derivados de 4,5-polimetileno-4-isotiazolin-3-onas
ES2054675T3 (es) Un procedimiento para la preparacion de isotiazolonas.
DE3765206D1 (de) Substituierte 2-aminotetraline.
ES2099727T3 (es) 8-azabiciclo(3.2.1)octilalquiltiazolidinonas, un procedimiento para su preparacion y su uso como medicamentos.
ES2089097T3 (es) Procedimiento para la fabricacion de derivados de bencilftalacinona y sales de la misma.
DE69204480D1 (de) Anilinderivate und Verfahren zu ihrer Herstellung.
DE69016266D1 (de) Aminoketonverbindungen.
DE69007203D1 (de) Imidazolderivate, Verfahren zu deren Herstellung und diese enthaltende Antiulkusmittel.
KR910004632A (ko) 신규한 1-옥사-2-옥소-8-아자스피로[4,5]데칸 유도체와 그들을 포함하는 약제학적 조성물 및 그 제조방법
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.
FI882956A (fi) 4-piperidyl-substituerade karboxylsyraderivat och foerfarande foer deras framstaellning.
ES2188478T3 (es) Procedimiento para la preparacion de un 1,1,1-trifluor-2-aminoalcano.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 699655

Country of ref document: ES